0001415889-23-005764.txt : 20230403 0001415889-23-005764.hdr.sgml : 20230403 20230403161140 ACCESSION NUMBER: 0001415889-23-005764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230401 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Kevin M. CENTRAL INDEX KEY: 0001971303 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 23792733 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-04032023_080434.xml X0407 4 2023-04-01 0001840233 Xilio Therapeutics, Inc. XLO 0001971303 Brennan Kevin M. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false SVP, FINANCE AND ACCOUNTING 0 Stock Option (right to buy) 3.17 2023-04-01 4 A 0 55000 0 A 2033-03-31 Common Stock 55000 55000 D The option was granted on April 1, 2023 and shall vest on March 30, 2024 with respect to 25% of the shares of common stock underlying the stock option, and the remaining 75% of the shares of common stock underlying the stock option shall continue to vest in 36 equal monthly installments thereafter until March 30, 2027. /s/ Julia Walcott, Attorney-in-Fact 2023-04-03